A Message from Consumer Action

Consumer Action's MoneyWi$e educational materials have moved to our Managing Money Project website. Here you may view, download and order bulk copies of the MoneyWi$e materials. Please make a note of the Managing Money Project address— www.managing-money.org —and add it to your address book.

A single-shot vaccine from Johnson & Johnson will be tested on 60,000

Source: Carolyn Johnson, Washington Post (Paid Registration)

The first coronavirus vaccine that aims to protect people with a single shot has entered the final stages of testing.  The experimental vaccine being developed by Johnson & Johnson is the fourth vaccine to enter the large, Phase 3 trials in the United States that will determine whether they are effective and safe. Paul Stoffels, chief scientific officer of J&J, predicted that there may be enough data to have results by the end of the year and said the company plans to manufacture 1 billion doses next year.

Read Full Article: A single-shot vaccine from Johnson & Johnson will be tested on 60,000

 

Quick Menu

Support Consumer Action

Support Consumer

Join Our Email List

Optional Member Code
Facebook FTwitter T

MoneyWise Modules

Managing Money Topics

Help Desk

Advocacy